ArticleScientific reports2017

Comparison of two-year outcomes after photodynamic therapy with ranibizumab or aflibercept for polypoidal choroidal vasculopathy.

Wataru Kikushima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.